Effects of Pneumococcal Conjugate Vaccine in the United Kingdom: Success of Vaccine Policy and Remaining Opportunities for Prevention
J Infect Dis
.
2020 Mar 28;221(8):1235-1237.
doi: 10.1093/infdis/jiz182.
Author
Tamara Pilishvili
1
Affiliation
1
Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
PMID:
31004131
DOI:
10.1093/infdis/jiz182
No abstract available
Publication types
Editorial
Comment
MeSH terms
Humans
Immunization*
Infant
Pneumococcal Vaccines*
Policy
Serogroup
United Kingdom
Vaccines, Conjugate
Substances
Pneumococcal Vaccines
Vaccines, Conjugate